← All trials
NCT05505825
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Aug 26, 2022
- Primary completion
- Dec 31, 2023
- Completion date
- Dec 31, 2025
- First posted
- Aug 18, 2022
- Last posted
- Nov 10, 2022
- Enrollment
- 42
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Akeso Pharmaceuticals, Inc.Lead sponsor
- Chipscreen Biosciences, Ltd.Collaborator
- Jilin UniversityOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.